Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

135

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A04AA05	PALONAN	G	Palonosetron HCl - 250mcg/5ml	250mcg/5ml	Injectable solution	2,194,495 L.L
B05BB02	DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	148,566 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	125,560,051 L.L
A04AA05	VONAXI	G	Palonosetron HCl - 250mcg/5ml	250mcg/5ml	Injectable solution	1,490,321 L.L
B05BB02	MIXTE SIMPLE (1)	G	Sodium chloride - 0.45g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	182,720 L.L
G03BA03	TESTOVIRON DEPOT	B	Testosterone Enantate - 250mg/ml	250mg/ml	Injectable solution	467,657 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	70,073,519 L.L
B05BB02	MIXTE SIMPLE (1)	G	Sodium chloride - 0.45g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	205,933 L.L
G03BA03	CYPTERONE	G	Testosterone Cypionate - 200mg/ml	200mg/ml	Injectable solution	618,168 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	36,881,038 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	193,062 L.L
L04AB04	ABRILADA	BioTech	Adalimumab - 40mg	40mg	Injectable solution	40,259,574 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	180,421 L.L
L04AB04	ABRILADA	BioTech	Adalimumab - 40mg	40mg	Injectable solution	40,259,574 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	236,731 L.L
L04AB04	ADALIREL	BioTech	Adalimumab - 40mg	40mg	Injectable solution	7,805,376 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	211,449 L.L
L04AB04	CINNORA	BioTech	Adalimumab - 40mg/0.8ml	40mg/0.8ml	Injectable solution	14,817,734 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	L.L
L02AE04	DECAPEPTYL SR	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	L.L
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units		Injectable powder for suspension+diluent	L.L
L02AE04	DECAPEPTYL SR	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL SR	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L
L02AE04	GONAPEPTYL CR	B	Triptorelin - 3.75mg	3.75mg	Injectable powder for suspension+diluent	12,095,730 L.L
J07BK01	VARIVAX	B	Varicella virus, live attenuated - 1350PFU		Injectable powder for suspension+diluent	4,102,751 L.L
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units		Injectable powder for suspension+diluent	18,750,588 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	39,355,784 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	59,034,407 L.L

...

135

...